Last mentioned: Feb 27, 2026
Novartis Settlement
Novartis resolves its legal dispute with the estate over the commercial use of HeLa cells.
Thermo Fisher Settlement
A landmark confidential settlement is reached, setting a precedent for the industry.
First Major Lawsuit
The Lacks estate files suit against Thermo Fisher Scientific on the 70th anniversary of her death.
HeLa Immortality
Researchers discover the cells can reproduce indefinitely, creating the first immortal human cell line.
Cells Harvested
Henrietta Lacks' cervical cancer cells are taken without consent at Johns Hopkins.
Novartis has reached a confidential settlement with the estate of Henrietta Lacks, resolving claims that the pharmaceutical giant unjustly profited from her 'immortal' cell line. This agreement marks a major milestone in the ongoing legal and ethical reckoning over the historical exploitation of Black patients in medical research.
This page surfaces every story mentioning Ben Crump across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Ben Crump was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |